156 related articles for article (PubMed ID: 36597540)
1. Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults.
Zhang Y; Romieu-Hernandez A; Boehmer TK; Azziz-Baumgartner E; Carton TW; Gundlapalli AV; Fearrington J; Nagavedu K; Dea K; Moyneur E; Cowell LG; Kaushal R; Mayer KH; Puro J; Rasmussen SA; Thacker D; Weiner MG; Saydeh S; Block JP;
medRxiv; 2022 Dec; ():. PubMed ID: 36597540
[TBL] [Abstract][Full Text] [Related]
2. Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.
Zhang Y; Romieu-Hernandez A; Boehmer TK; Azziz-Baumgartner E; Carton TW; Gundlapalli AV; Fearrington J; Nagavedu K; Dea K; Moyneur E; Cowell LG; Kaushal R; Mayer KH; Puro J; Rasmussen SA; Thacker D; Weiner MG; Saydah S; Block JP;
BMC Infect Dis; 2024 Feb; 24(1):181. PubMed ID: 38341566
[TBL] [Abstract][Full Text] [Related]
3. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.
Funk AL; Kuppermann N; Florin TA; Tancredi DJ; Xie J; Kim K; Finkelstein Y; Neuman MI; Salvadori MI; Yock-Corrales A; Breslin KA; Ambroggio L; Chaudhari PP; Bergmann KR; Gardiner MA; Nebhrajani JR; Campos C; Ahmad FA; Sartori LF; Navanandan N; Kannikeswaran N; Caperell K; Morris CR; Mintegi S; Gangoiti I; Sabhaney VJ; Plint AC; Klassen TP; Avva UR; Shah NP; Dixon AC; Lunoe MM; Becker SM; Rogers AJ; Pavlicich V; Dalziel SR; Payne DC; Malley R; Borland ML; Morrison AK; Bhatt M; Rino PB; Beneyto Ferre I; Eckerle M; Kam AJ; Chong SL; Palumbo L; Kwok MY; Cherry JC; Poonai N; Waseem M; Simon NJ; Freedman SB;
JAMA Netw Open; 2022 Jul; 5(7):e2223253. PubMed ID: 35867061
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2.
Hernandez-Romieu AC; Carton TW; Saydah S; Azziz-Baumgartner E; Boehmer TK; Garret NY; Bailey LC; Cowell LG; Draper C; Mayer KH; Nagavedu K; Puro JE; Rasmussen SA; Trick WE; Wanga V; Chevinsky JR; Jackson BR; Goodman AB; Cope JR; Gundlapalli AV; Block JP
JAMA Netw Open; 2022 Feb; 5(2):e2147053. PubMed ID: 35119459
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program.
Rao S; Lee GM; Razzaghi H; Lorman V; Mejias A; Pajor NM; Thacker D; Webb R; Dickinson K; Bailey LC; Jhaveri R; Christakis DA; Bennett TD; Chen Y; Forrest CB
medRxiv; 2022 May; ():. PubMed ID: 35665016
[TBL] [Abstract][Full Text] [Related]
6. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program.
Varma JK; Zang C; Carton TW; Block JP; Khullar DJ; Zhang Y; Weiner MG; Rothman RL; Schenck EJ; Xu Z; Lyman K; Bian J; Xu J; Shenkman EA; Maughan C; Castro-Baucom L; O'Brien L; Wang F; Kaushal R;
PLoS One; 2024; 19(6):e0282451. PubMed ID: 38843159
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents.
Rao S; Lee GM; Razzaghi H; Lorman V; Mejias A; Pajor NM; Thacker D; Webb R; Dickinson K; Bailey LC; Jhaveri R; Christakis DA; Bennett TD; Chen Y; Forrest CB
JAMA Pediatr; 2022 Oct; 176(10):1000-1009. PubMed ID: 35994282
[TBL] [Abstract][Full Text] [Related]
8. Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program.
Khullar D; Zhang Y; Zang C; Xu Z; Wang F; Weiner MG; Carton TW; Rothman RL; Block JP; Kaushal R
J Gen Intern Med; 2023 Apr; 38(5):1127-1136. PubMed ID: 36795327
[TBL] [Abstract][Full Text] [Related]
9. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program.
Varma JK; Zang C; Carton TW; Block JP; Khullar DJ; Zhang Y; Weiner MG; Rothman RL; Schenck EJ; Xu Z; Lyman K; Bian J; Xu J; Shenkman EA; Maughan C; Castro-Baucom L; O'Brien L; Wang F; Kaushal R
medRxiv; 2023 Feb; ():. PubMed ID: 36865304
[TBL] [Abstract][Full Text] [Related]
10. Association between acquiring SARS-CoV-2 during pregnancy and post-acute sequelae of SARS-CoV-2 infection: RECOVER electronic health record cohort analysis.
Bruno AM; Zang C; Xu Z; Wang F; Weiner MG; Guthe N; Fitzgerald M; Kaushal R; Carton TW; Metz TD; ;
EClinicalMedicine; 2024 Jul; 73():102654. PubMed ID: 38828129
[TBL] [Abstract][Full Text] [Related]
11. Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California.
Young-Wolff KC; Slama N; Alexeeff SE; Sakoda LC; Fogelberg R; Myers LC; Campbell CI; Adams AS; Prochaska JJ
Nicotine Tob Res; 2023 Jan; 25(2):211-220. PubMed ID: 35368066
[TBL] [Abstract][Full Text] [Related]
12. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
13. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
Xie Y; Choi T; Al-Aly Z
JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
[TBL] [Abstract][Full Text] [Related]
15. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
18. Evolving phenotypes of non-hospitalized patients that indicate long COVID.
Estiri H; Strasser ZH; Brat GA; Semenov YR; ; Patel CJ; Murphy SN
BMC Med; 2021 Sep; 19(1):249. PubMed ID: 34565368
[TBL] [Abstract][Full Text] [Related]
19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
20. Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
Roberts SC; Jolley SE; Beaty LE; Aggarwal NR; Bennett TD; Carlson NE; Fish LE; Kwan BM; Russell S; Wogu AF; Wynia MA; Ginde AA
J Med Virol; 2024 Mar; 96(3):e29541. PubMed ID: 38516779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
